Joseph Disa, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1710962709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,585 of the $20,803 with a category attached, or 84.5%. 15 manufacturers reported payments, led by Sientra, Inc. at 54.4% of the total. Reporting peaked in 2022 at $8,051 and has fallen 83.5% since, to $1,329 in 2025. Among plastic and reconstructive surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $104.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$11K
- Davol Inc.$4K
- AbbVie$1K
- Axogen$1K
- Tepha Inc$943
- Bard Peripheral Vascular, Inc.$335
- plus $1K from 9 others
What the payments were for
- Speaking & faculty fees$3,21815%
- Food & beverage$17,58585%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 100 | $11,323 |
| Davol Inc. | 14 | $4,149 |
| AbbVie(2 entities) | 41 | $1,419 |
| Axogen | 13 | $1,286 |
| Tepha Inc | 12 | $943 |
| Bard Peripheral Vascular, Inc. | 5 | $335 |
| BD | 3 | $227 |
| Vioptix Inc | 1 | $222 |
| RTI Surgical, Inc | 3 | $219 |
| Mentor Worldwide LLC | 3 | $196 |
| Motiva USA, LLC | 1 | $168 |
| Kerecis Limited | 1 | $151 |
| Avita Medical Americas, LLC | 1 | $108 |
| Integra Lifesciences Corporation | 1 | $32 |
| TELA Bio, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$9,342
- Kerecis SurgiClose$605
- ARISTA AH FLEXITIP$563
- GalaFLEX$524
- AVANCE NERVE GRAFT$441
- Phasix Mesh$316
- ALLODERM$282
- NATRELLE$226
- Motiva Implant Matrix$168
- AxoGuard Nerve Connector$157
- AxoGuard Nerve Protector$157
- AXOGUARD HA+ NERVE PROTECTOR$157
- AxoGuard Nerve Cap$157
- CORTIVA ALLOGRAFT DERMIS$155
- Kerecis GraftGuide$151
- RECELL$108
- MENTOR MemoryGel Resterilizable Gel Sizer$108
- PROGEL$104
How this compares
$20,803 in reported general payments places this provider in the 90th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in New York
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Theodore DiktabanNew York$83K
- Lawrence BassNew York$37K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
- Graham SchwarzNew York$16K
- Evan MatrosNew York$15K
- Anna SteveNew York$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.